Logo image of SRXH

SRX HEALTH SOLUTIONS INC (SRXH) Stock Fundamental Analysis

USA - NYSEARCA:SRXH - US08771Y4026 - Common Stock

0.331 USD
+0.01 (+3.41%)
Last: 10/24/2025, 8:04:01 PM
0.326 USD
-0.01 (-1.51%)
After Hours: 10/24/2025, 8:04:01 PM
Fundamental Rating

1

Taking everything into account, SRXH scores 1 out of 10 in our fundamental rating. SRXH was compared to 39 industry peers in the Consumer Staples Distribution & Retail industry. SRXH may be in some trouble as it scores bad on both profitability and health. SRXH is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year SRXH has reported negative net income.
SRXH had a negative operating cash flow in the past year.
SRXH had negative earnings in 4 of the past 5 years.
SRXH had negative operating cash flow in 4 of the past 5 years.
SRXH Yearly Net Income VS EBIT VS OCF VS FCFSRXH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M

1.2 Ratios

SRXH has a Return On Assets of -47.34%. This is amonst the worse of the industry: SRXH underperforms 92.31% of its industry peers.
Industry RankSector Rank
ROA -47.34%
ROE N/A
ROIC N/A
ROA(3y)-79.59%
ROA(5y)-70.15%
ROE(3y)-316.39%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SRXH Yearly ROA, ROE, ROICSRXH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K -10K

1.3 Margins

The Gross Margin of SRXH (34.80%) is better than 79.49% of its industry peers.
In the last couple of years the Gross Margin of SRXH has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for SRXH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 34.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.59%
GM growth 5Y-0.26%
SRXH Yearly Profit, Operating, Gross MarginsSRXH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20K -40K -60K -80K

More info and screens

0

2. Health

2.1 Basic Checks

SRXH does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SRXH has more shares outstanding
Compared to 5 years ago, SRXH has more shares outstanding
The debt/assets ratio for SRXH has been reduced compared to a year ago.
SRXH Yearly Shares OutstandingSRXH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M
SRXH Yearly Total Debt VS Total AssetsSRXH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

SRXH has an Altman-Z score of -6.46. This is a bad value and indicates that SRXH is not financially healthy and even has some risk of bankruptcy.
SRXH has a Altman-Z score of -6.46. This is amonst the worse of the industry: SRXH underperforms 94.87% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -6.46
ROIC/WACCN/A
WACC7.71%
SRXH Yearly LT Debt VS Equity VS FCFSRXH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

SRXH has a Current Ratio of 0.33. This is a bad value and indicates that SRXH is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of SRXH (0.33) is worse than 92.31% of its industry peers.
SRXH has a Quick Ratio of 0.33. This is a bad value and indicates that SRXH is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.26, SRXH is doing worse than 79.49% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.33
Quick Ratio 0.26
SRXH Yearly Current Assets VS Current LiabilitesSRXH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 94.29% over the past year.
SRXH shows a small growth in Revenue. In the last year, the Revenue has grown by 5.31%.
SRXH shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.56% yearly.
EPS 1Y (TTM)94.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.45%
Revenue 1Y (TTM)5.31%
Revenue growth 3Y-8.73%
Revenue growth 5Y17.56%
Sales Q2Q%34.04%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y273.33%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year25%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SRXH Yearly Revenue VS EstimatesSRXH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
SRXH Yearly EPS VS EstimatesSRXH Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 0 -10 -20 -30

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SRXH. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 1.25, the valuation of SRXH can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SRXH indicates a rather cheap valuation: SRXH is cheaper than 100.00% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of SRXH to the average of the S&P500 Index (22.92), we can say SRXH is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 1.25
SRXH Price Earnings VS Forward Price EarningsSRXH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SRXH Per share dataSRXH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SRXH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SRX HEALTH SOLUTIONS INC

NYSEARCA:SRXH (10/24/2025, 8:04:01 PM)

After market: 0.326 -0.01 (-1.51%)

0.331

+0.01 (+3.41%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)09-30 2025-09-30/amc
Earnings (Next)11-10 2025-11-10
Inst Owners1.03%
Inst Owner ChangeN/A
Ins Owners20.55%
Ins Owner Change0%
Market Cap8.23M
Revenue(TTM)37.14M
Net Income(TTM)-16088000
Analysts82.86
Price Target10.2 (2981.57%)
Short Float %4.46%
Short Ratio0.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1.25
P/S 0.22
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.15
EYN/A
EPS(NY)0.27
Fwd EY80.12%
FCF(TTM)-0.85
FCFYN/A
OCF(TTM)-0.77
OCFYN/A
SpS1.49
BVpS-1.85
TBVpS-1.89
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -47.34%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 34.8%
FCFM N/A
ROA(3y)-79.59%
ROA(5y)-70.15%
ROE(3y)-316.39%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.59%
GM growth 5Y-0.26%
F-Score2
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 70.32%
Cap/Sales 5.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.33
Quick Ratio 0.26
Altman-Z -6.46
F-Score2
WACC7.71%
ROIC/WACCN/A
Cap/Depr(3y)14.78%
Cap/Depr(5y)14.84%
Cap/Sales(3y)0.18%
Cap/Sales(5y)0.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)94.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.45%
EPS Next Y273.33%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.31%
Revenue growth 3Y-8.73%
Revenue growth 5Y17.56%
Sales Q2Q%34.04%
Revenue Next Year25%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-86.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year147.5%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-140.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-117.4%
OCF growth 3YN/A
OCF growth 5YN/A

SRX HEALTH SOLUTIONS INC / SRXH FAQ

What is the ChartMill fundamental rating of SRX HEALTH SOLUTIONS INC (SRXH) stock?

ChartMill assigns a fundamental rating of 1 / 10 to SRXH.


What is the valuation status for SRXH stock?

ChartMill assigns a valuation rating of 4 / 10 to SRX HEALTH SOLUTIONS INC (SRXH). This can be considered as Fairly Valued.


What is the profitability of SRXH stock?

SRX HEALTH SOLUTIONS INC (SRXH) has a profitability rating of 1 / 10.


How financially healthy is SRX HEALTH SOLUTIONS INC?

The financial health rating of SRX HEALTH SOLUTIONS INC (SRXH) is 0 / 10.


Is the dividend of SRX HEALTH SOLUTIONS INC sustainable?

The dividend rating of SRX HEALTH SOLUTIONS INC (SRXH) is 0 / 10 and the dividend payout ratio is 0%.